Comorbidity Profile of Dementia Patients in Primary Care: Are They Sicker?

Journal of the American Geriatrics Society - Tập 54 Số 1 - Trang 104-109 - 2006
Cathy C. Schubert1, Malaz Boustani1, Christopher M. Callahan1, Anthony J. Perkins1, Caroline P. Carney1, Chris Fox1, Frederick W. Unverzagt1, Siu Hui1, Hugh C. Hendrie1
1Indiana University, Bloomington, United States

Tóm tắt

OBJECTIVES: To compare the medical comorbidity of older patients with and without dementia in primary care.DESIGN: Cross‐sectional study.SETTING: Wishard Health Services, which includes a university‐affiliated, urban public hospital and seven community‐based primary care practice centers in Indianapolis.PARTICIPANTS: Three thousand thirteen patients aged 65 and older attending seven primary care centers in Indianapolis, Indiana.MEASUREMENTS: An expert panel diagnosed dementia using International Classification of Diseases, 10th Revision, criteria. Comorbidity was assessed using 10 physician‐diagnosed chronic comorbid conditions and the Chronic Disease Score (CDS).RESULTS: Patients with dementia attending primary care have on average 2.4 chronic conditions and receive 5.1 medications. Approximately 50% of dementia patients in this setting are exposed to at least one anticholinergic medication, and 20% are prescribed at least one psychotropic medication. After adjusting for patients' age, race, and sex, patients with and without dementia have a similar level of comorbidity (mean number of chronic medical conditions, 2.4 vs 2.3, P=.66; average CDS, 5.8 vs 6.2, P=.83).CONCLUSION: Multiple medical comorbid conditions are common in older adults with and without dementia in primary care. Despite their cholinergic deficit, a substantial proportion of patients with dementia are exposed to anticholinergic medications. Models of care that incorporate this medical complexity are needed to improve the treatment of dementia in primary care.

Từ khóa


Tài liệu tham khảo

10.1001/archinte.162.20.2269

Boustani M, 2003, Screening for dementia in primary care, A summary of the evidence for the U.S. Preventive Services Task Force, 138, 927

10.1111/j.1532-5415.1994.tb04974.x

Larson EB, 1984, Dementia in elderly outpatients, A prospective study, 100, 417

10.1111/j.1532-5415.2004.52052.x

10.1097/00019442-200307000-00009

10.1111/j.1532-5415.2004.52054.x

10.1097/00002093-200207000-00002

10.7326/0003-4819-122-6-199503150-00004

10.1111/j.1525-1497.2005.0126.x

10.1093/geront/44.4.548

10.1097/00005650-200209000-00007

10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F

10.1212/WNL.39.9.1159

10.1176/ajp.152.10.1485

1991, International Statistical Classification of Diseases and Related Health Problems

10.1016/0895-4356(92)90016-G

10.1097/00005650-199508000-00004

10.1016/j.jclinepi.2004.03.002

10.1001/archinte.161.8.1099

Mulsant BH, 2003, Serum anticholinergic activity in a community‐based sample of older adults, Relationship with cognitive performance, 60, 198

10.1176/appi.ajp.161.1.116

Tune L, 1992, Anticholinergic effects of drugs commonly prescribed for the elderly, Potential means for assessing risk of delirium, 149, 1393

10.1093/gerona/57.3.M173

10.1136/bmj.323.7319.945

Bogardus ST, 2004, Achieving goals in geriatric assessment, Role of caregiver agreement and adherence to recommendations, 52, 99

10.1111/j.1532-5415.1988.tb01804.x

10.1177/153331750201700210

Lieberman JA., 2004, Managing anticholinergic side effects, Prim Care Companion J Clin Psychiatry, 6, 20

Aizenberg D, 2002, Anticholinergic burden and the risk of falls among elderly psychiatric inpatients, A 4-year case-control study, 14, 307

10.1001/jama.1994.03510260066030

10.1097/00019442-199802000-00005

Blazer DG, 1983, The risk of anticholinergic toxicity in the elderly, A study of prescribing practices in two populations, 38, 31

Fick DM, 2002, Delirium superimposed on dementia, A systematic review, 50, 1723

Lyketsos CG, 2000, Mental and behavioral disturbances in dementia, Findings from the Cache County Study on Memory in Aging, 157, 708